DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
6.22
-0.43 (-6.47%)
At close: Nov 6, 2025, 4:00 PM EST
6.22
0.00 (0.00%)
After-hours: Nov 6, 2025, 4:10 PM EST
DiaMedica Therapeutics Employees
As of December 31, 2024, DiaMedica Therapeutics had 28 total employees, including 27 full-time and 1 part-time employees. The number of employees increased by 9 or 47.37% compared to the previous year.
Employees
28
Change (1Y)
9
Growth (1Y)
47.37%
Revenue / Employee
n/a
Profits / Employee
-$1,056,429
Market Cap
321.51M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 28 | 9 | 47.37% |
| Dec 31, 2023 | 19 | 3 | 18.75% |
| Dec 31, 2022 | 16 | 1 | 6.67% |
| Dec 31, 2021 | 15 | 4 | 36.36% |
| Dec 31, 2020 | 11 | 2 | 22.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
DMAC News
- 5 weeks ago - DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Business Wire
- 2 months ago - DiaMedica Therapeutics to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - DiaMedica Therapeutics to Participate in Cantor Global Healthcare Conference - Business Wire
- 3 months ago - DiaMedica: Interim Results Brings Study Expansions For DM199 In Preeclampsia - Seeking Alpha
- 3 months ago - DiaMedica Therapeutics Inc. (DMAC) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - DiaMedica Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights - Business Wire
- 3 months ago - DiaMedica Therapeutics Appoints Julie Krop, MD, as Chief Medical Officer - Business Wire
- 3 months ago - DiaMedica Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update August 13, 2025 - Business Wire